Aurore Blesius

Identification of a Small Interface between the Methyltransferase and RNA Polymerase of NS5 that is Essential for Zika Virus Replication

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

Combination of Zoledronic Acid and Targeted Therapy Is Active But May Induce Osteonecrosis of the Jaw in Patients With Metastatic Renal Cell Carcinoma

Breast cancer

Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases

Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors

Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial

Bone health in cancer patients: ESMO Clinical Practice Guidelines

Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases

A phase I study of cabozantinib (XL184) in patients with renal cell cancer

Second Line Chemotherapy for Advanced and Metastatic Urothelial Carcinoma: Vinflunine and Beyond—A Comprehensive Review of the Current Literature

Pancreatic cancer: why is it so hard to treat?

American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update

Second-Line Systemic Therapy for Metastatic Urothelial Carcinoma of the Bladder

Accelerated MVAC chemotherapy in patients with advanced bladder cancer previously treated with a platinum–gemcitabine regimen

Cytidine Deaminase Residual Activity in Serum Is a Predictive Marker of Early Severe Toxicities in Adults After Gemcitabine-Based Chemotherapies

Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib

Fuhrman grade and concomitant bisphosphonates as additional prognostic factors in metastatic renal cell carcinoma with bone metastases treated with sunitinib.